SYNEKTIK
Research SYNEKTIK (SNT.WA) on Bullrun: market cap PLN 2.83B, P/E 15.8, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNT.WA
- ExchangeXWAR
- CountryPoland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyPLN
- Market capPLN 2.83B
- P/E15.8
- Dividend yield3.1%
- Financial periodQ2 2026
- RevenuePLN 292.26M
- Net incomePLN 55.08M
- Free cash flowPLN 62.32M
- Gross margin32.4%
Valuation Snapshot
latest market cap is PLN 2.83B; P/E is 15.8; dividend yield is 3.1%.
Peer valuation comparison
Latest P/E is 15.85x versus a Healthcare sector median of 23.44x (32.4% below).
Latest dividend yield is 3.05% versus a Healthcare sector median of 2.1% (45.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-06 | PLN 2.83B | 15.8 | 3.2% | 10.75 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 10.75 PLN, yield 3.1%.
About SYNEKTIK
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SYNEKTIK's market cap?
SYNEKTIK's market capitalization is PLN 2.83B.
What is SYNEKTIK's P/E ratio?
SYNEKTIK's price-to-earnings (P/E) ratio is 15.8.
Does SYNEKTIK pay a dividend?
SYNEKTIK has a dividend yield of 3.1%.
What does SYNEKTIK do?
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.